Sten Nilsson
Board of Director
Management
Spago Imaging
Sweden
Biography
Born 1948, Board member since 2013. Sten Nilsson, MD, PhD is a professor of oncology with affiliation to Karolinska Institutet. Sten Nilsson, a specialist in oncology and nuclear medicine, was responsible for study design and was the principal investigator for the early clinical development of Xofigo ™ (formerly Alpharadin ™). Sten Nilsson is a member of the Swedish Cancer Fund Research Committee
Research Interest
Nanotechnology
